Product Information
VYZULTA 0.024% OPHTH SOLUTION is a brand product labeled by Bausch & Lomb Incorporated, priced at $102.2893 per ML under NDC 24208050402. Its NADAC has been published 396 times since Jan 23, 2019.
FDA first approved this application on Nov 2, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.24 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208050402
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
LATANOPROSTENE BUNODApproval Type
New Drug (NDA)
FDA Application
NDA207795FDA Approved
11/2/2017
TE Code
AB
On Market Since
11/2/2017
Price Statistics
The NADAC for VYZULTA 0.024% OPHTH SOLUTION has been published 396 times since Jan 23, 2019, and over the history we have for it it has risen 48.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $102.2893 per ML |
|---|---|
| All-time high | $102.4567 (May 13, 2026) |
| All-time low | $68.9624 (Jan 23, 2019) |
| 52-week high | $102.4567 |
| 52-week low | $99.4216 |
| Median price | $87.4633 |
| Average price | $88.5113 |
| Largest weekly change | +6.0% (Jan 12, 2022) |
| Weeks tracked | 396 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VYZULTA 0.024% OPHTH SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for VYZULTA 0.024% OPHTH SOLUTION, manufactured by Bausch & Lomb Incorporated, is $102.2893 per ML (NDC 24208050402), effective Aug 19, 2026.
How has the price of VYZULTA 0.024% OPHTH SOLUTION changed over time?
Over the history we have for it, the NADAC for VYZULTA 0.024% OPHTH SOLUTION has risen 48.3%. It has been tracked across 396 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for VYZULTA 0.024% OPHTH SOLUTION?
Since Jan 23, 2019, the NADAC for VYZULTA 0.024% OPHTH SOLUTION has ranged from a low of $68.9624 (Jan 23, 2019) to a high of $102.4567 (May 13, 2026), with a median of $87.4633 per ML.
Are there cheaper alternatives to VYZULTA 0.024% OPHTH SOLUTION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VYZULTA 0.024% OPHTH SOLUTION, is $102.2475 per ML — about 0% below VYZULTA 0.024% OPHTH SOLUTION.
Who manufactures VYZULTA 0.024% OPHTH SOLUTION?
VYZULTA 0.024% OPHTH SOLUTION (NDC 24208050402) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.